Praveen Tyle

Dr. Praveen Tyle is a Non-Executive Chairman at Kiora Pharmaceuticals, Inc., an Independent Director at Orient Europharma Co. Ltd. and a Chief Executive Officer & Director at Orion Biotechnology Canada Ltd. He is on the Board of Directors at Lipomedix Pharmaceuticals Ltd., Orient Europharma Co. Ltd., Orion Biotechnology Canada Ltd., Interpath Pharmaceuticals, Inc. and Maxwell Biosciences, Inc. Dr. Tyle was previously employed as a Founder by Potens Pharmaceuticals LLC, an Independent Director by Skye Bioscience, Inc., a President, Chief Executive Officer & Director by Invectys, Inc., a Non-Executive Director by GI Dynamics, Inc., an Executive Vice President-Research & Development by Lexicon Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by Osmotica Pharmaceutical Corp., a Chief Science Officer & Executive Vice President by The United States Pharmacopeia, a SVP, Global Head-Business Development & Licensing by Novartis Consumer Health, Inc., a Chief Scientific Officer by Bausch & Lomb, Inc., a Group VP-Pharmaceutical Sciences & Manufacturing by Biovail Corp.
International, a VP-Global Head & Global Pharmaceutical Sciences by Pharmacia Corp., a Chief Technical Officer & SVP-Operations by Aronex Pharmaceuticals, Inc., a Senior Advisor by Arsenal Capital Management LP, and a President, Chief Executive Officer & Director by Invectys USA, Inc. He also served on the board at Ramboda Falls Plc and Graybug Vision, Inc. He received his undergraduate degree from Banaras Hindu University and a doctorate degree from The Ohio State University.